North America Diagnostics Labs Market Outlook, 2029
The North America Diagnostic labs Market is segmented into By Testing Services (General and Clinical Testing, Physiological Function Testing (ECG, Echo, X-ray, Endoscopy, CT, MRI, and Others), Esoteric Testing, Specialized Testing, Non-invasive Prenatal Testing, Others), By Lab Type (Hospital-Based Labs, Single/Independent Laboratories, Physician Office Labs, Others), By Revenue Source (Healthcare Plan Operators and Insurers, Out-of-Pocket, Public System, Speciality Store , Online Retail).
- Bonafide Research
- 31-01-2024
- Pages : 86
- Figures : 12
- Tables : 20
- Region : North America
- Category : Lifescience
- Healthcare
The North America Diagnostic Lab market was valued at more than USD 120 Billion in 2023 due to growing healthcare expenditure
- Historical Period2018-2022
- Base Year2023
- Forecast Period2024-2029
- Market Size (2023) USD 120 Billion
- Largest Market United States
- Fastest Market Canada
- Format
Featured Companies
- 1. Abbott Laboratories
- 2. F. Hoffmann-La Roche AG,
- 3. Laboratory Corporation
- 4. Siemens Healthineers
- 5. Quest Diagnostics
- 6. Thermo Fisher Scientific Inc
- More...
Diagnostic labs Market Market Analysis
The North American diagnostic laboratory market stands as a cornerstone within the region's extensive and sophisticated healthcare landscape, playing a pivotal role in disease diagnosis, health monitoring, and medical research. Spanning the United States and Canada, this market reflects the culmination of advanced technological capabilities, stringent regulatory standards, and a commitment to delivering cutting-edge diagnostic services. Diagnostic labs in North America cater to a diverse and dynamic population, contributing significantly to the early detection and management of various medical conditions. With a focus on precision medicine, personalised diagnostics, and a wide array of testing services ranging from routine screenings to specialised molecular diagnostics, the North American diagnostic laboratory market embodies the forefront of innovation in healthcare diagnostics. North America experiences a high volume of diagnostic testing, ranging from routine screenings to complex genetic and molecular tests. This reflects a proactive approach to healthcare, with an emphasis on early detection and prevention. With advancements in genomics, North America has witnessed significant growth in genomic testing services. This includes genetic testing for hereditary conditions, cancer genomics, and pharmacogenomics for personalised medication management. There is a growing emphasis on wellness and preventive care in North America, leading to increased demand for diagnostic tests related to lifestyle, nutrition, and early disease detection. The region serves as a hub for research and development in the field of diagnostics. Academic institutions, research centres, and diagnostic labs collaborate to advance scientific knowledge and develop innovative diagnostic technologies. According to the research report "North America Diagnostic Lab Market Outlook, 2029," published by Bonafide Research, the North America Diagnostic Lab market was valued at more than USD 120 Billion in 2023. There is a growing emphasis on preventive healthcare in North America, encouraging individuals to undergo regular check-ups and screenings. Diagnostic labs play a crucial role in preventive care by offering a range of tests for early detection of diseases, contributing to increased demand. The region faces a high burden of chronic diseases such as diabetes, cardiovascular diseases, and cancer. Diagnostic labs are essential for the ongoing monitoring and management of these conditions, driving demand for tests related to disease diagnosis and progression. The shift towards precision medicine, which involves tailoring medical treatment based on individual characteristics, relies heavily on advanced diagnostic testing. Genetic and molecular diagnostics play a key role in identifying personalised treatment strategies, contributing to the demand for specialised tests. Increasing awareness among consumers about the importance of health screenings and early detection contributes to a proactive approach to healthcare. Individuals are more likely to seek diagnostic tests for preventive and wellness purposes. Ongoing research and development initiatives in healthcare and diagnostics contribute to the introduction of new and advanced diagnostic tests. These innovations drive demand for state-of-the-art testing services. Public health initiatives that focus on disease prevention, vaccination, and screening programmes contribute to increased demand for diagnostic services. These initiatives aim to detect and manage health issues at the population level.
Click Here to Download this information in a PDF
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamic
Market Drivers • Rising chronic disease Burden: The prevalence of chronic diseases, including diabetes, cardiovascular diseases, and cancer, is on the rise in North America. Diagnostic labs play a crucial role in the early detection, monitoring, and management of these conditions, driving sustained demand for testing services. • Preventive Healthcare Initiatives: There is a growing emphasis on preventive healthcare initiatives, encouraging individuals to undergo regular screenings and diagnostic tests for early disease detection. Preventive healthcare programmes contribute to increased demand for diagnostic services. • Consumer Awareness: Increasing awareness among consumers about the importance of health screenings, early detection, and personalised medicine contributes to a proactive approach to healthcare. Informed consumers are more likely to seek diagnostic tests for preventive and wellness purposes. Market Challenges • Increasing Test Complexity: Advances in diagnostic technologies have led to the development of more complex tests, including molecular diagnostics and genetic testing. While these tests provide valuable insights, their complexity can pose challenges in terms of interpretation, validation, and standardisation. • Patient Access and Health Disparities: Ensuring equitable access to diagnostic services remains a challenge, particularly in addressing health disparities among different demographic groups. Socioeconomic factors, geographical location, and disparities in healthcare access can impact patient outcomes. Market Opportunity • Genomic and Molecular Diagnostics: Advances in genomics and molecular diagnostics open doors for diagnostic labs to offer more comprehensive genetic testing, personalised medicine services, and targeted therapies. The expanding field of precision diagnostics contributes to improved patient outcomes. • Population Health Management: Diagnostic labs have the opportunity to play a key role in population health management by providing data-driven insights into health trends, disease prevalence, and risk factors. Collaborating with healthcare providers and public health agencies can support proactive health interventions.
Diagnostic labs Market Segmentation
| By Testing Services | General and Clinical Testing | |
| Physiological Function Testing (ECG, Echo, X-ray, Endoscopy, CT, MRI, and Others) | ||
| Esoteric Testing | ||
| Specialized Testing | ||
| Non-invasive Prenatal Testing | ||
| Others | ||
| By Lab Type | Single/Independent Laboratories | |
| Physician Office Labs | ||
| Others | ||
| By Revenue Source | Healthcare Plan Operators and Insurers | |
| Out-of-Pocket | ||
| Public System | ||
| North America | United States | |
| Canada | ||
| Mexico | ||
Based on testing services, they are segmented into general and clinical testing, physiological function testing (ECG, echo, X-ray, endoscopy, CT, MRI, and others), esoteric testing, specialised testing, non-invasive prenatal testing, and others. North America places a strong emphasis on preventive healthcare, encouraging individuals to undergo regular check-ups and screenings. General and clinical testing, including routine blood tests, lipid panels, and metabolic screenings, align with the preventive healthcare approach, contributing to a high volume of such tests. The region faces a high prevalence of chronic diseases such as diabetes, cardiovascular diseases, and obesity. General and clinical testing are essential for monitoring these conditions, assessing treatment effectiveness, and making informed decisions in chronic disease management. Many general and clinical tests are routinely conducted in physician office labs (POLs) across North America. These labs, often located within healthcare facilities, offer convenient access to a variety of tests, contributing to the prevalence of general and clinical testing. Public health initiatives and population health screening programmes often focus on general and clinical testing. These programmes aim to identify prevalent health issues at the population level, contributing to disease prevention and management. General and clinical tests are commonly included in routine health check-ups. Individuals, as part of their regular healthcare routine, undergo screenings to assess their overall health status, detect potential issues, and receive guidance for lifestyle management. In terms of the lab types, they are segmented into hospital-based labs, single or independent laboratories, physician office labs, and others. Many independent labs specialise in specific diagnostic services or testing categories. This specialisation allows them to develop expertise in particular areas, offering a niche service that caters to the needs of healthcare providers and patients seeking specialised testing. Independent labs may offer cost-effective diagnostic services. Their smaller size and focused operations can lead to lower overhead costs, allowing them to provide competitive pricing for various tests, which can be attractive to both patients and healthcare providers. Many independent labs house a team of skilled professionals, including pathologists, laboratory scientists, and technicians. This in-house expertise contributes to the accuracy and reliability of test results, instilling confidence in healthcare providers and patients. Independent labs are often more responsive to local healthcare trends and needs. Their ability to align with specific regional health priorities allows them to offer services that address prevalent health issues in their service areas. Independent labs are agile and can quickly adopt new technologies and innovations in the diagnostic field. This adaptability enables them to stay at the forefront of advancements, offering state-of-the-art testing services to their clientele. According to the report, revenue sources are segmented into healthcare plan operators and insurers, out-of-pocket, and public systems; among them, the public system is a growing market. Public healthcare systems in North America, such as those in Canada, receive substantial government funding. This funding supports public health initiatives, including diagnostic testing programs. Publicly funded diagnostic labs often play a crucial role in providing essential services for the population. Public diagnostic labs secure contracts and partnerships with government healthcare agencies. These contracts often involve providing a range of diagnostic services to the public, contributing to the revenue generation of these labs. Publicly funded labs receive support for research and development activities. This can include developing and implementing innovative diagnostic technologies and methodologies, contributing to advancements in the field. During public health crises, such as the COVID-19 pandemic, publicly funded labs play a critical role in testing and surveillance efforts. The surge in demand for diagnostic testing during emergencies can significantly contribute to the revenue generated by these labs. Furthermore, out-of-pocket expenses contribute to the market; some diagnostic tests are not fully covered by health insurance plans. In such cases, patients are required to cover the costs out of pocket. This can be applicable to certain types of tests, specialised diagnostics, or screening services that may not be included in standard insurance coverage. The growing trend of individuals proactively seeking wellness and lifestyle testing may lead to out-of-pocket payments. Wellness testing often involves a range of diagnostic services that individuals choose to undergo for health optimisation and preventive purposes.
Click Here to Download this information in a PDF
Diagnostic labs Market Market Regional Insights
Based on the report, the major countries covered in the report include the United States, Canada, Mexico, and the rest of North America; among them, the United States contributes the highest market share. The United States has one of the largest and most diverse healthcare markets globally. The sheer size of the population and the healthcare infrastructure create a substantial demand for diagnostic lab services. The predominant private healthcare system in the U.S. contributes to a robust market for diagnostic labs. Private laboratories, both independent and those affiliated with healthcare institutions, play a significant role in meeting the diagnostic needs of the population. Furthermore, the U.S. healthcare system is known for its emphasis on innovation and the early adoption of advanced medical technologies. This includes diagnostic technologies and testing methodologies. The constant pursuit of cutting-edge diagnostic capabilities contributes to the growth of the market. As well, the United States is a hub for research and development in healthcare. This includes the development of new diagnostic tests, technologies, and methodologies. The presence of research institutions, biotechnology companies, and academic collaborations fosters innovation in diagnostic lab services. There is a growing emphasis on preventive healthcare in the United States, with individuals opting for regular check-ups and screenings. Diagnostic labs play a crucial role in supporting preventive care initiatives, contributing to a high volume of tests. The overall economic strength of the United States supports healthcare spending, including expenditures on diagnostic services. Economic factors, such as disposable income and healthcare investments, contribute to the market share of diagnostic labs.
Click Here to Download this information in a PDF
Companies Mentioned
- Abbott Laboratories
- F. Hoffmann-La Roche AG,
- Laboratory Corporation
- Siemens Healthineers
- Quest Diagnostics
- Thermo Fisher Scientific Inc
- Eurofins Scientific SE
- Exact Sciences Corp
- SYNLAB Group
- Sonic Healthcare Limited
- SGS S.A.
- Myriad Genetics, Inc
Table of Contents
- Table of Contents
- 1. Executive Summary
- 2. Research Methodology
- 2.1. Secondary Research
- 2.2. Primary Data Collection
- 2.3. Market Formation & Validation
- 2.4. Report Writing, Quality Check & Delivery
- 3. Market Structure
- 3.1. Market Considerate
- 3.2. Assumptions
- 3.3. Limitations
- 3.4. Abbreviations
- 3.5. Sources
- 3.6. Definitions
- 4. Economic /Demographic Snapshot
- 5. Global Diagnostic Lab Market Outlook
- 5.1. Market Size By Value
- 5.2. Market Share By Region
- 5.3. Market Size and Forecast, By Testing Services
- 5.4. Market Size and Forecast, By Lab Type
- 5.5. Market Size and Forecast, By Revenue Source
- 6. North America Diagnostic Lab Market Outlook
- 6.1. Market Size By Value
- 6.2. Market Share By Country
- 6.3. Market Size and Forecast, By Testing Services
- 6.4. Market Size and Forecast, By Lab Type
- 7. Market Dynamics
- 7.1. Market Drivers & Opportunities
- 7.2. Market Restraints & Challenges
- 7.3. Market Trends
- 7.4. Covid-19 Effect
- 7.5. Supply chain Analysis
- 7.6. Policy & Regulatory Framework
- 7.7. Industry Experts Views
- 7.8. Market Size and Forecast, By Revenue Source
- 7.9. United States Diagnostic Lab Market Outlook
- 7.9.1. Market Size By Value
- 7.9.2. Market Size and Forecast By Testing Services
- 7.9.3. Market Size and Forecast By Lab Type
- 7.9.4. Market Size and Forecast By Revenue Source
- 7.10. Canada Diagnostic Lab Market Outlook
- 7.10.1. Market Size By Value
- 7.10.2. Market Size and Forecast By Testing Services
- 7.10.3. Market Size and Forecast By Lab Type
- 7.10.4. Market Size and Forecast By Revenue Source
- 7.11. Mexico Diagnostic Lab Market Outlook
- 7.11.1. Market Size By Value
- 7.11.2. Market Size and Forecast By Testing Services
- 7.11.3. Market Size and Forecast By Lab Type
- 7.11.4. Market Size and Forecast By Revenue Source
- 8. Competitive Landscape
- 8.1. Competitive Dashboard
- 8.2. Business Strategies Adopted by Key Players
- 8.3. Porter's Five Forces
- 8.4. Company Profile
- 8.4.1. Eurofins Scientific SE
- 8.4.1.1. Company Snapshot
- 8.4.1.2. Company Overview
- 8.4.1.3. Financial Highlights
- 8.4.1.4. Geographic Insights
- 8.4.1.5. Business Segment & Performance
- 8.4.1.6. Product Portfolio
- 8.4.1.7. Key Executives
- 8.4.1.8. Strategic Moves & Developments
- 8.4.2. Quest Diagnostics
- 8.4.3. F. Hoffmann-La Roche AG
- 8.4.4. Thermo Fisher Scientific Inc.
- 8.4.5. Exact Sciences Corp
- 8.4.6. Abbott Laboratories
- 8.4.7. Siemens Healthineers AG
- 8.4.8. SYNLAB Group
- 8.4.9. Sonic Healthcare Limited
- 8.4.10. SGS S.A.
- 8.4.11. Laboratory Corporation of America Holdings
- 8.4.12. Myriad Genetics, Inc
- 9. Strategic Recommendations
- 10. Annexure
- 10.1. FAQ`s
- 10.2. Notes
- 10.3. Related Reports
- 11. Disclaimer
Table 1: Global Diagnostic Lab Market Snapshot, By Segmentation (2023 & 2029) (in USD Billion)
Table 2: Top 10 Counties Economic Snapshot 2022
Table 3: Economic Snapshot of Other Prominent Countries 2022
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5: Global Diagnostic Lab Market Size and Forecast, By Testing Services (2018 to 2029F) (In USD Billion)
Table 6: Global Diagnostic Lab Market Size and Forecast, By Lab Type (2018 to 2029F) (In USD Billion)
Table 7: Global Diagnostic Lab Market Size and Forecast, By Revenue Source (2018 to 2029F) (In USD Billion)
Table 8: North America Diagnostic Lab Market Size and Forecast, By Testing Services (2018 to 2029F) (In USD Billion)
Table 9: North America Diagnostic Lab Market Size and Forecast, By Lab Type (2018 to 2029F) (In USD Billion)
Table 10: Influencing Factors for Diagnostic Lab Market, 2023
Table 11: North America Diagnostic Lab Market Size and Forecast, By Revenue Source (2018 to 2029F) (In USD Billion)
Table 12: United States Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 13: United States Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 14: United States Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 15: Canada Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 16: Canada Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 17: Canada Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 18: Mexico Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 19: Mexico Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 20: Mexico Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Figure 1: Global Diagnostic Lab Market Size (USD Billion) By Region, 2023 & 2029
Figure 2: Market attractiveness Index, By Region 2029
Figure 3: Market attractiveness Index, By Segment 2029
Figure 4: Global Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 5: Global Diagnostic Lab Market Share By Region (2023)
Figure 6: North America Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 7: North America Diagnostic Lab Market Share By Country (2023)
Figure 8: US Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 9: Canada Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 10: Mexico Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 11: Competitive Dashboard of top 5 players, 2023
Figure 12: Porter's Five Forces of Global Diagnostic Lab Market
Diagnostic labs Market Market Research FAQs
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (26 December, 2024)
- Notify To Team (26 December, 2024)
- Report updation (27 December, 2024)
- Report Quality Check (27 December, 2024)
- Report Dispatch (28 December, 2024)
- Hard Copy
Recently Viewed Products
North America Diagnostics Labs Market Outlook, 2029
We are friendly and approachable, give us a call.